The raised guidance and strong Q1 beat (especially on GAAP EPS) should drive positive momentum. Watch for continued organic growth in Diagnostics (3.1% organic) and Central Labs (11.3% growth). The $8.64B backlog (+5.6% YoY) provides visibility into Biopharma revenue. Monitor upcoming acquisitions and the new Central Lab facility investment.
LH drugs
LH drug pipeline →How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 30 $256.10entry
- T+1 · 7mo ago −0.37%α −0.59% · $255.14
- T+5 · 6mo ago +0.49%α −1.24% · $257.34
- T+20 · 6mo ago +1.55%α −3.68% · $260.06
- T+60 · 4mo ago +17.60%α +14.49% · $301.17
Price Chart
How similar events traded
Executive Summary
Labcorp reported Q1 2026 revenue of $3.54B (+5.8% YoY) and diluted GAAP EPS of $3.35 (+32.8% YoY), beating consensus estimates. The company raised its full-year 2026 Adjusted EPS guidance to $17.70-$18.35 (up $0.13 at the midpoint) and enterprise revenue growth guidance to 5.0%-6.1%. Strong operational performance across both Diagnostics and Biopharma segments, coupled with raised guidance, signals accelerating momentum.
Key Financial Metrics
Key Facts
- Q1 2026 revenue of $3.54B, up 5.8% YoY from $3.35B
- Diluted GAAP EPS of $3.35, up 32.8% YoY from $2.52
- Adjusted EPS of $4.25, up 10.6% YoY from $3.84
- Raised FY2026 Adjusted EPS guidance to $17.70-$18.35 (prior $17.55-$18.25)
- Raised FY2026 enterprise revenue growth guidance to 5.0%-6.1% (prior 4.7%-6.0%)
- Diagnostics segment revenue $2.76B (+5.0% YoY), AOI margin 16.6% (+30bps)
- Biopharma segment revenue $780.6M (+8.2% YoY), AOI margin 15.5% (+60bps)
- Free cash flow of $70.5M vs -$107.5M in prior year quarter
- Backlog of $8.64B, up 5.6% YoY
- Repurchased $98M of stock and paid $61.2M in dividends in Q1
Financial Impact
Raised FY2026 Adjusted EPS midpoint by $0.13 to $18.03, revenue midpoint increased by ~$25M to $14.725B
Risk Factors
- Organic revenue growth of 3.1% is modest and below total reported growth of 5.8%
- Total debt increased to $6.33B from $5.58B at year-end due to debt pre-funding
- Accounts receivable increased $187.9M, pressuring working capital
- Adverse weather impacted organic volume growth (1.1% vs 1.8% price/mix)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000920148-26-000135 |
| Document: lh-20260430.htm | 0000920148-26-000135 |
| Document: 0000920148-26-000135-index-headers.html | 0000920148-26-000135 |
| Document: 0000920148-26-000135-index.html | 0000920148-26-000135 |
| Document: 0000920148-26-000135.txt | 0000920148-26-000135 |
| 8-K Data (Synthetic) | 0000920148-26-000135 |
Track record
29 reports on LH
4 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +14.54% at T+20 after the Oct 15, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $372.32 Now $372.46 +0.04% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $372.23 Now $372.46 +0.06% settles Nov 18
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $363.30 to $372.32 Now $372.46 +2.52% ▲ +2.48% −0.81% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 4, 202612d ago 8-K Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $353.92 to $370.88 Now $372.46 +5.24% ▲ +4.79% +5.38% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $361.39 to $366.57 Now $372.46 +3.06% ▲ +1.43% +4.14% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $360.25 to $367.79 Now $372.46 +3.39% ▲ +2.09% +2.81% vs SPY
- Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $329.90 to $361.39 Now $372.46 +12.90% ▲ +9.55% +10.81% vs SPY
- Oct 21, 202626d ago 8-K Neutral 2/10 Entry $323.75 to $331.17 Now $372.46 +15.05% ▲ +2.29% +2.74% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers